Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction - PubMed (original) (raw)
Affiliations
- PMID: 1868040
Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction
S S Hom et al. J Immunother (1991). 1991 Jun.
Abstract
Major histocompatibility complex (MHC) class I antigens (Ag), particularly human lymphocyte antigen (HLA)-A2, have been shown to function as restriction elements in human cytotoxic T lymphocyte recognition of tumor. This study was undertaken to determine the function of non-A2 MHC class I Ag in tumor recognition by tumor-infiltrating lymphocytes (TILs) cultured from six melanomas, and to find evidence for shared or unique tumor-associated Ag. Four predominantly CD8+ and two mixed CD4+, CD8+ population TIL cultures were tested for lysis in short-term 51Cr-release assays against a panel of targets including 29 fresh melanomas, 2 fresh sarcomas, 11 cultured melanoma lines, and 14 nonmelanoma cell lines derived from HLA-typed patients. All six melanoma TILs lysed the autologous melanoma. Two of three TILs from HLA-A2+ patients lysed allogeneic melanomas matched for HLA-A2, giving evidence for shared tumor Ag; one of these TILs also used HLA-B44 as a restriction element. The third HLA-A2+ TIL lysed autologous melanoma but not autologous Epstein-Barr virus-transformed B cells nor 14 HLA-A2 matched allogeneic melanomas, suggesting the possibility of a unique tumor Ag in this system. The three HLA-A2- TILs each lysed multiple HLA-matched melanomas, using HLA-A24, HLA-A31, and HLA-Cw7 as restriction elements. Blocking of autologous and allogeneic melanoma lysis by TILs with mAb w6/32 (anti-MHC class I) and anti-CD3, as well as cold target inhibition assays, confirmed that specific interaction of the T-cell receptor with MHC class I Ag and the relevant tumor Ag on the target cell surface is required for tumor lysis. These data provide evidence for specific recognition of shared melanoma Ag by human TILs.
Similar articles
- Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.
Kawakami Y, Zakut R, Topalian SL, Stötter H, Rosenberg SA. Kawakami Y, et al. J Immunol. 1992 Jan 15;148(2):638-43. J Immunol. 1992. PMID: 1729379 - HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer.
Peoples GE, Goedegebuure PS, Andrews JV, Schoof DD, Eberlein TJ. Peoples GE, et al. J Immunol. 1993 Nov 15;151(10):5481-91. J Immunol. 1993. PMID: 8228240 - T-cell recognition of human melanoma antigens.
Kawakami Y, Nishimura MI, Restifo NP, Topalian SL, O'Neil BH, Shilyansky J, Yannelli JR, Rosenberg SA. Kawakami Y, et al. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):88-93. doi: 10.1097/00002371-199308000-00002. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280705 Free PMC article. Review. - Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes.
Topalian SL, Hom SS, Kawakami Y, Mancini M, Schwartzentruber DJ, Zakut R, Rosenberg SA. Topalian SL, et al. J Immunother (1991). 1992 Oct;12(3):203-6. doi: 10.1097/00002371-199210000-00013. J Immunother (1991). 1992. PMID: 1445813 Review.
Cited by
- Prostate cancer health disparities: An immuno-biological perspective.
Kumar S, Singh R, Malik S, Manne U, Mishra M. Kumar S, et al. Cancer Lett. 2018 Feb 1;414:153-165. doi: 10.1016/j.canlet.2017.11.011. Epub 2017 Nov 15. Cancer Lett. 2018. PMID: 29154974 Free PMC article. - Focus on adoptive T cell transfer trials in melanoma.
Hershkovitz L, Schachter J, Treves AJ, Besser MJ. Hershkovitz L, et al. Clin Dev Immunol. 2010;2010:260267. doi: 10.1155/2010/260267. Epub 2010 Dec 26. Clin Dev Immunol. 2010. PMID: 21234353 Free PMC article. Review. - In vitro biological activities of transmembrane superantigen staphylococcal enterotoxin A fusion protein.
Ma W, Yu H, Wang Q, Bao J, Yan J, Jin H. Ma W, et al. Cancer Immunol Immunother. 2004 Feb;53(2):118-24. doi: 10.1007/s00262-003-0437-0. Epub 2003 Oct 22. Cancer Immunol Immunother. 2004. PMID: 14574492 Free PMC article. - Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy.
Colella TA, Bullock TN, Russell LB, Mullins DW, Overwijk WW, Luckey CJ, Pierce RA, Restifo NP, Engelhard VH. Colella TA, et al. J Exp Med. 2000 Apr 3;191(7):1221-32. doi: 10.1084/jem.191.7.1221. J Exp Med. 2000. PMID: 10748239 Free PMC article. - The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
Litton MJ, Dohlsten M, Rosendahl A, Ohlsson L, Søgaard M, Andersson J, Andersson U. Litton MJ, et al. Br J Cancer. 1999 Sep;81(2):359-66. doi: 10.1038/sj.bjc.6690701. Br J Cancer. 1999. PMID: 10496366 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials